Mixed-Backbone Oligonucleotides for Therapeutics: The Way of the Future
Conventional oligonucleotides, such as DNA and RNA, are extensively modified for therapeutic applications. The mixed-backbone oligonucleotides (MBOs) that are generated by combining different classes have superior properties such as enhanced mRNA binding affinity, improved distribution, and reduced toxicity. Oligonuc...